Literature DB >> 10956324

The future: cardiovascular medicine in 10 years.

K Swedberg1.   

Abstract

Mesh：

Substances：

Year:  2000        PMID： 10956324      PMCID： PMC1766528          DOI： 10.1136/heart.84.suppl_1.i48

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  2 in total

1.  Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II.

Authors:  B Pitt; P A Poole-Wilson; R Segal; F A Martinez; K Dickstein; A J Camm; M A Konstam; G Riegger; G H Klinger; J Neaton; D Sharma; B Thiyagarajan
Journal:  Lancet       Date:  2000-05-06       Impact factor: 79.321

2.  ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither. The ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.

Authors:  C Baigent; R Collins; P Appleby; S Parish; P Sleight; R Peto
Journal:  BMJ       Date:  1998-05-02
  2 in total
  1 in total

1.  Development of a Group Judgment Process for Forecasts of Health Care Innovations.

Authors:  Paul G Shekelle; Dana P Goldman
Journal:  JAMA Netw Open       Date:  2018-11-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.